64
Participants
Start Date
June 5, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Autologous Whole Blood Management
Intraoperative high volume autologous whole blood withdrawal with re-transfusion following weaning from CPB.
Standard Care involving allogenic and/or derivative transfusion.
Therapeutic treatment of CPB-induced coagulopathy using donated allogenic blood products including plasma, platelets, and cryoprecipitate and/or derivative administration using prothrombin complex and fibrinogen concentrates.
RECRUITING
University of Alberta, Edmonton
Collaborators (1)
University Hospital Foundation
OTHER
Alberta Innovates Health Solutions
OTHER
EPICORE Centre
UNKNOWN
University of Alberta
OTHER